Quantifying the impact of expanded age group campaigns for polio eradication

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wagner, Bradley G ^a   Behrend, Matthew R ^a   Klein, Daniel J ^a   Upfill Brown, Alexander M ^a   Eckhoff, Philip A ^a   Hu, Hao ^a  

^a INSTITUTE FOR DISEASE MODELING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

AGE; AGE DISTRIBUTION; ARTICLE; DISEASE ERADICATION; HUMAN; INFECTION CONTROL; MATHEMATICAL ANALYSIS; NIGERIA; POLIOMYELITIS; PROGRAM IMPACT; PUBLIC HEALTH; SEROPREVALENCE; VACCINATION; VIRUS IMMUNITY; VIRUS INFECTIVITY; ADOLESCENT; ADULT; CHILD; IMMUNIZATION; IMMUNOLOGY; INFANT; MUCOSAL IMMUNITY; PRESCHOOL CHILD; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; INFANT; MODELS, STATISTICAL; POLIOMYELITIS; YOUNG ADULT;

EID: 84914689003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113538     Document Type: Article

References (26)

1. World Health Assembly (2012) World Health Assembly Resolution: Completion of polio eradication programmatic emergency for global public health. Available: http://apps.who.int/gb/ebwha/pdf-files/WHA65/A65-R5-en.pdf.
2. World Health Organization (2013) Polio Eradication and Endgame Strategic Plan 2013-2018. Available: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/GPEI-Plan- FactFile-EN.pdf
3. Behrend M, Hu H, Nigmatulina K, Eckhoff P (2013) A quantitative survey of the literature on poliovirus infection and immunity. Int J Infect Dis 18: 4-13.
4. Callaway E (2013) Public health: Polio's moving target. Nature 496: 290-292.
5. Green MS, Handsher R, Cohen D, Melnick JL, Slepon R, et al. (1993) Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization. Vaccine 11: 75-81.
6. Zhang J, Yu J, Linkins R, Zhang R, Wang K, et al. (1997) Effect of target age of supplemental immunization campaigns of poliomyelitis occurence in China. J Infect Dis 175: S210-14.
7. Giwa F, Olayinka A, Ogunshola F (2012) Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria. Vaccine 30: 6759-65.
8. Nates SV, Martinez LC, Barril PA, Ferreyra LJ, Giordano MO, et al. (2007) Long-Lasting Poliovirus- Neutralizing Antibodies among Argentinean Population Immunized with Four Or Five Oral Polio Vaccine Doses 1 Month to 19 Years Previously. Viral Immunology 20: 3-10.
9. Nishio O, Ishihara Y, Sakae K, Nonomura Y, Kuno A, et al. (1984) The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years. Journal of Biological Standardization 12: 1-10.
10. Dick GWA, Dane DS, McAlister J, Nelson R, Field CMB (1961) Vaccination against poliommyelitis with live virus vaccines 7. Effect Of Previous Salk Vaccination On Virus Excretion. British Medical Journal 2: 266-269.
11. Davis DC, Lipson MJ, Carver DH, Melnick JL, Robbins FC (1958) The degree and duration of poliomyelitis virus excretion among vaccinated household contacts of clinical cases of poliomyelitis. Pediatrics 22: 33-40.
12. Alexander JP, Gary HE, Pallansch MA (1997) Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 175: S176-182.
13. Ghendon YZ, Sanakoyeva II (1961) Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity. Acta Virologica 5: 265-273.
14. Fine PE, Carneiro IA (1999) Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 150: 1001-1021.
15. Mayer BT, Eisenberg JN, Henry CJ, Gomes MG, Ionides EL, et al. (2013) Successes and shortcomings of polio eradication: a transmission modeling analysis. Am J Epidemiol 177: 1236-1245.
16. Wringe A, Fine PEM, Sutter RW, Kew OM (2008) Estimating the extent of vaccine-derived poliovirus infection. PLoS ONE 3: e3433.
17. Bottiger M (1984) Long-Term Immunity following Vaccination with Killed Poliovirus Vaccine in Sweden, a Country with No Circulating Poliovirus. Reviews of Infectious Diseases 6: S548-S551.
18. Bottiger M (1990) Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 8: 443-445.
19. Faden H, Duffy L, Sun M, Shuff C (1993) Long-Term Immunity to Poliovirus in Children Immunized with Live Attenuated and Enhanced-Potency Inactivated Trivalent Poliovirus Vaccines. J Infect Dis 168: 452-454.
20. Grotto I, Handsher R, Gdalevich M, Mimouni D, Huerta M, et al. (2001) Decline in immunity to polio among young adults. Vaccine 19: 4162-4166.
21. Fox JP (1984) Modes of action of poliovirus vaccines and relation to resulting immunity. Reviews of Infectious Diseases 6 Suppl. 2: S352-S355.
22. Haas CN, Rose JB, Gerba CP (2014) Quantitative Microbial Risk Assessment: Wiley.
23. Nathanson N, Martin JR (1979) The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol 110: 672.
24. Raftery AE, Bao L (2010) Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling. Biometrics 66: 1162-1173.
25. Poole D, Raftery E (2000) Inference for deterministic simulation models: The Bayesian melding approach. Journal of the American Statistical Association 95: 1244-1255.
26. Blake IM, Martin R, Goel A, Khetsurani N, Everts J, et al. (2014) The role of older children and adults in wild poliovirus transmission. Proc Natl Acad Sci USA 111: 10604-10609.